Improving the health of insulin-producing cells in type-2 diabetes
Official title: Targeting PFKFB3 kinase for activation of cell competition and elimination of dysfunctional beta-cells in type-2 diabetes
Funded at Metanoia Bio LLC · NIH-10922398 · Data updated 2026-11-12
This study is looking at a new way to help people with type-2 diabetes by targeting a specific enzyme to help the body get rid of unhealthy insulin-producing cells and replace them with healthy ones, which could lead to better treatment options for managing the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Metanoia Bio LLC NIH-funded |
| Lab location | 1 site (Beverly Hills, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $295,257 |
| NIH project number | 1R41DK139901-01 |
| Project ID | NIH-10922398 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are diagnosed with type-2 diabetes and have dysfunctional beta-cells.
✕Less likely to help
Patients with type-1 diabetes or those who do not have issues with beta-cell function may not benefit from this research.
What this research studies
This research investigates a new approach to treat type-2 diabetes by targeting a specific enzyme, PFKFB3, to enhance the body's ability to eliminate dysfunctional insulin-producing beta-cells. The study aims to restore the natural process of cell competition, which helps replace damaged cells with healthy ones. By using a novel mouse model, researchers will explore how activating this enzyme can improve beta-cell function and potentially reverse the progression of diabetes. Patients may benefit from a more effective treatment strategy that focuses on restoring cell health rather than just increasing insulin production.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that restore normal function in insulin-producing cells, improving diabetes management.
How similar studies have gone: Previous studies have shown promising results in enhancing cell competition and improving cell function in diabetes, indicating that this approach may be viable.
Where this research is happening
-
Metanoia Bio LLC
Beverly Hills, United States Active
Researchers
- Principal investigator: Greeff, Oppel — Metanoia Bio LLC
- Study coordinator: Greeff, Oppel
Related research
Other NIH-funded projects on the same topics.
-
Subtyping Core for Research on the Causes of Type 2 Diabetes (SCORE-T2D)
A new U01 grant from a university research team aims to understand why Type 2 diabetes differs so much between people and how to tailor prevention and treatment.
-
Michigan Diabetes Project: A Peer-Led Self-Management Program for Adults with Type 2 Diabetes
A peer-led self-management program for adults with type 2 diabetes is being tested to see if it improves blood sugar control and daily diabetes care.
-
Alzheimer’s and dementia risk in people with prediabetes or type 2 diabetes
This grant aims to understand why some older adults with prediabetes or type 2 diabetes develop memory problems or dementia.
-
Personalized use of newer diabetes medicines for Type 2 diabetes
Aiming to tailor use of newer glucose-lowering drugs for people with type 2 diabetes to improve health and access in real-world settings.
-
Alzheimer’s and related dementia in older adults with prediabetes or type 2 diabetes
This grant aims to understand why cognitive problems occur in people 65 and older who have prediabetes or type 2 diabetes, using data from a long-running diabetes study to identify what drives memory and thinking decline.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.